Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
J Autoimmun
; 103: 102289, 2019 09.
Article
in En
| MEDLINE
| ID: mdl-31176558
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Antigen, T-Cell
/
T-Lymphocytes, Cytotoxic
/
Immunotherapy, Adoptive
/
T-Lymphocytes, Regulatory
/
Diabetes Mellitus, Type 1
/
Receptors, Chimeric Antigen
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
J Autoimmun
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2019
Type:
Article
Affiliation country:
Germany